4.3 Editorial Material

Will cyclopentenyl cytosine (CPEC) ever have a future in the clinic?

Journal

LEUKEMIA RESEARCH
Volume 32, Issue 2, Pages 201-202

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2007.06.020

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure

Sandra Perez-Torras, Aida Mata-Ventosa, Britt Drogemoller, Maja Tarailo-Graovac, Judith Meijer, Rutger Meinsma, Arno G. van Cruchten, Wim Kulik, Albert Viel-Oliva, Axel Bidon-Chanal, Colin J. Ross, Wyeth W. Wassermann, Clara D. M. van Karnebeek, Marcal Pastor-Anglada, Andre B. P. van Kuilenburg

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)

Article Oncology

A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy

Linda M. Henricks, Carin A. T. C. Lunenburg, Femke M. de Man, Didier Meulendijks, Geert W. J. Frederix, Emma Kienhuis, Geert-Jan Creemers, Arnold Baars, Vincent O. Dezentje, Alexander L. T. Imholz, Frank J. F. Jeurissen, Johanna E. A. Portielje, Rob L. H. Jansen, Paul Hamberg, Albert J. ten Tije, Helga J. Droogendijk, Miriam Koopman, Peter Nieboer, Marlene H. W. van de Poel, Caroline M. P. W. Mandigers, Hilde Rosing, Jos H. Beijnen, Erik van Werkhoven, Andre B. P. van Kuilenburg, Ron H. N. van Schaik, Ron H. J. Mathijssen, Jesse J. Swen, Hans Gelderblom, Annemieke Cats, Henk-Jan Guchelaar, Jan H. M. Schellens

EUROPEAN JOURNAL OF CANCER (2019)

Article Oncology

Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients

I. R. N. Verly, R. Leen, J. R. Meinsma, G. K. J. Hooijer, C. D. Savci-Heijink, J. van Nes, M. Broekmans, R. J. A. Wanders, A. B. P. van Kuilenburg, G. A. M. Tytgat

EUROPEAN JOURNAL OF CANCER (2019)

Article Pharmacology & Pharmacy

Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation

Mohammed H. Aldosari, Robert P. de Vries, Lucia R. Rodriguez, Nienke A. Hesen, Nataliia Beztsinna, Andre B. P. van Kuilenburg, Carla E. M. Hollak, Huub Schellekens, Enrico Mastrobattista

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)

Review Endocrinology & Metabolism

Developments in the treatment of Fabry disease

Sanne J. van der Veen, Carla E. M. Hollak, Andre B. P. van Kuilenburg, Mirjam Langeveld

JOURNAL OF INHERITED METABOLIC DISEASE (2020)

Review Endocrinology & Metabolism

Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers

Eline C. B. Eskes, Barbara Sjouke, Frederic M. Vaz, Susan M. I. Goorden, Andre B. P. van Kuilenburg, Johannes M. F. G. Aerts, Carla E. M. Hollak

MOLECULAR GENETICS AND METABOLISM (2020)

Letter Critical Care Medicine

The Effects of Mercaptopurine on Pulmonary Vascular Resistance and BMPR2 Expression in Pulmonary Arterial Hypertension

Liza Botros, Robert Szulcek, Samara M. A. Jansen, Kondababu Kurakula, Marie-Jose T. H. Goumans, Andre B. P. van Kuilenburg, Anton Vonk Noordegraaf, Frances S. de Man, Jurjan Aman, Harm Jan Bogaard

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease

Sanne J. van der Veen, Wytze J. Vlietstra, Laura van Dussen, Andre B. P. van Kuilenburg, Marcel G. W. Dijkgraaf, Malte Lenders, Eva Brand, Christoph Wanner, Derralynn Hughes, Perry M. Elliott, Carla E. M. Hollak, Mirjam Langeveld

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Genetics & Heredity

Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients

Shanice Beerepoot, Silvy J. M. van Dooren, Gajja S. Salomons, Jaap Jan Boelens, Edwin H. Jacobs, Marjo S. van der Knaap, Andre B. P. van Kuilenburg, Nicole Wolf

NEUROGENETICS (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake

Thomas Blom, Rutger Meinsma, Marja Rutgers, Corine Buitenhuis, Marieke van den Burg, Andre B. P. van Kuilenburg, Godelieve A. M. Tytgat

EJNMMI RESEARCH (2020)

Article Genetics & Heredity

Atypical presentation of Arts syndrome due to a novel hemizygous loss-of-function variant in the PRPS1 gene

Sanna Puusepp, Karit Reinson, Sander Pajusalu, Andre B. P. van Kuilenburg, Doreen Dobritzsch, Jeroen Roelofsen, Werner Stenzel, Katrin Ounap

MOLECULAR GENETICS AND METABOLISM REPORTS (2020)

Article Oncology

Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population

Jatta Saarenheimo, Nesna Wahid, Natalja Eigeliene, Ravichandra Ravi, Gajja S. Salomons, Matilde Fernandez Ojeda, Raymon Vijzelaar, Antti Jekunen, Andre B. P. van Kuilenburg

Summary: This study describes the application of upfront DPD screening in Finnish patients, revealing that 8% of patients carried pathogenic DPYD variants causing DPD deficiency, including a novel intragenic deletion. The high prevalence of exon 4 deletion among Finnish patients emphasizes the importance of full-scale DPYD gene analysis and the use of genotype preemptive screening to detect DPD-deficient patients before fluoropyrimidine therapy.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)

Article Genetics & Heredity

Co-therapy with S-adenosylmethionine and nicotinamide riboside improves t-cell survival and function in Arts Syndrome (PRPS1 deficiency)

Nina Lenherr, John Christodoulou, John Duley, Doreen Dobritzsch, Lynette Fairbanks, Alexandre N. Datta, Isabel Filges, Nicolas Guertler, Jeroen Roelofsen, Andre B. P. van Kuilenburg, Claudia Kemper, Erin E. West, Gabor Szinnai, Martina Huemer

Summary: Arts syndrome is caused by mutations in the PRPS1 gene, leading to symptoms such as hearing loss, optic atrophy, muscular hypotonia, developmental impairment, and early respiratory infections. Treatment with S-adenosylmethionine (SAM) and nicotinamide riboside has shown improvements in clinical phenotype and T-cell survival and function.

MOLECULAR GENETICS AND METABOLISM REPORTS (2021)

Article Pharmacology & Pharmacy

Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation

Andre B. P. van Kuilenburg, Carla E. M. Hollak, Ana Travella, Melisa Jacobs, Lucas D. Gentilini, Rene Leen, Karen M. M. Ghauharali van der Vlugt, Femke S. Beers Stet, Susan M. I. Goorden, Sanne van der Veen, Marcelo Criscuolo, Mariana Papouchado

Summary: This study found that the biosimilar AGABIO had similar amino acid sequence, glycosylation, enzymatic activity, and stability to agalsidase beta. It also showed comparable effects in cultured Fabry fibroblasts and Fabry mice. These findings support the biosimilarity of AGABIO to agalsidase beta.

DRUGS IN R&D (2023)

Article Urology & Nephrology

Early Risk Stratification for Natural Disease Course in Fabry Patients Using Plasma Globotriaosylsphingosine Levels

Sanne J. van der Veen, Mohamed el Sayed, Carla E. M. Hollak, Marion M. Brands, C. Khya S. Snelder, S. Matthijs Boekholdt, Liffert Vogt, Susan M. I. Goorden, Andre B. P. van Kuilenburg, Mirjam Langeveld

Summary: Fabry disease is a heterogeneous X-linked lysosomal storage disease with varying manifestations in the kidneys, heart, and brain even among patients of the same sex and classification. The study investigates the association between plasma lysoGb3 levels and disease manifestations in untreated patients with Fabry disease, and finds that higher levels of lysoGb3 are associated with disease progression in various organs.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

No Data Available